Pazan, Farhad
Petrovic, Mirko
Cherubini, Antonio
Cruz-Jentoft, Alfonso J.
Denkinger, Michael
van der Cammen, Tischa J. M.
Stevenson, Jennifer M.
Ibrahim, Kinda
Rajkumar, Chakravarthi
Bakken, Marit Stordal
Crome, Peter
Guðmundsson, Adalsteinn
Knol, Wilma
Snijders, Birgitta M. G.
O’Mahony, Denis
Serra-Rexach, José Antonio
Soulis, George
van Marum, Rob J.
Ziere, Gijsbertus
Mair, Alpana
Burkhardt, Heinrich
Neumann-Podczaska, Agnieszka
Wieczorowska-Tobis, Katarzyna
Fernandes, Marilia Andreia
Gruner, Heidi
van der Velde, Nathalie
Wehling, Martin
Funding for this research was provided by:
Medizinische Fakultät Mannheim der Universität Heidelberg
Article History
Accepted: 19 September 2022
First Online: 26 October 2022
Declarations
:
: FP & MW contributed to the study conception and design. FP performed project administration and data collection. FP, MP, KI, GZ, ANP, KWT, BS, AG, WK, CR, AC, HB, MD, DOM, HG, MAF, TJMC, PC, JS, AM, ACJ, NVV, MSB, JASR, GS and RM screened all studies and assessed the risk of bias and quality of evidence. The manuscript was written by FP & MW. All authors contributed to validation of eligible studies, data analysis, and visualisation, commented on previous versions of the manuscript and approved the final draft.
: Open Access funding enabled and organized by Projekt DEAL.
: MW was employed by AstraZeneca R&D, Mölndal, as director of discovery medicine (translational medicine) from 2003 to 2006, while on sabbatical leave from his professorship at the University of Heidelberg. Since returning to this position in January 2007, he has received lecturing and consulting fees from Bristol Myers, Bayer, Boehringer-Ingelheim, LEO, Mundipharma, Novartis, Pfizer, Polyphor, Helsinn, Allergan, Allecra, Novo-Nordisk, Heel, AstraZeneca, Roche, Santhera, Sanofi-Aventis, Shire, Berlin-Chemie und Daichii-Sankyo. FP, MP, KI, GZ, ANP, KWT, BS, AG, WK, CR, AC, HB, MD, DOM, HG, MAF, TJMC, PC, JS, AM, ACJ, NVV, MSB, JASR, GS and RM have no COIs to declare.
: Available upon request.
: Not applicable
: Not applicable
: Not applicable
: Not applicable